No Detail Found!

Efficacy of Interrupted and Modified Deferasirox Dose among Paediatric Patients with ?- Thalassemia Major and High Alanine Aminotransferase Level.

Author(s)
Nashwan M AL Hafidh Department of Paediatrics, College of Medicine, Ninevah University,Mosul-,Iraq
Abstract
Background: Abnormal liver function tests lead to interruptions of Deferasirox therapy. The aim of this study is to assess the efficacy of deferasirox dose 30 mg /kg /day in maintaining cardiac protective level of serum ferritin of 2500 ng/ml, and was associated with 55 times relative risk of having mean serum ferritin >2500 ng/ml compared to group B with steady median deferasirox dose. Conclusions: Interrupted and modified deferasirox dose of 30 mg/kg/day has a significant adverse effect on cardiac protective level of serum ferritin.
Publication Details
Page(s) 182-184
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 31, Issue: 2, Year: 2019

Request the full text from PASTIC

Keywords
alanine aminotransferase, ß- thalassemia major, Serum ferritin
0

Citations

0

Downloads

93

Views